Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy [NA]
This clinical trial evaluates Superb Microvascular Imaging and two-dimensional EUS-guided shear wave elastography to differentiate pancreati…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer [NA]
A clinical trial entry describing the Alpha DaRT diffusing alpha-emitters radiation therapy device for locally advanced or unresectable panc…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer [NA]
This update describes a feasibility and safety study of intratumoral diffusing alpha radiation emitters for advanced pancreatic cancer. The …
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion [Phase 1]
Bristol-Myers Squibb is conducting a Phase 1 trial of MRTX1719 in MTAP-deleted solid tumors, including mesothelioma, non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating sequential GEMBRAX followed by FOLFIRINOX and then stereotactic MRI-guided radiotherapy for locally a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI [Phase 2]
Phase 2 trial evaluating dostarlimab for locally advanced or metastatic dMMR/MSI cancers excluding colorectal and endometrial, across multip…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer [NA]
Clinical trial update indicates Alpha Tau Medical's alpha radiation emitter device is being studied for advanced pancreatic cancer and is cu…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer [Phase 1]
This is a Phase 1 clinical trial update for a combination of calaspargase pegol-mnkl and cobimetinib in locally advanced or metastatic pancr…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
Clinical trial update reports the completion of a Phase 1/2 safety and efficacy study of CTX131 in adults with relapsed or refractory solid …
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Surgery for Locally Unresectable Pancreatic Cancer
A clinical trial sponsored by Azienda Ospedaliera di Padova is currently recruiting to evaluate surgery for locally unresectable locally adv…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy [NA]
This clinical trial update describes PROACTIVE, a study assessing surgical resection outcomes after neoadjuvant chemotherapy in locally adva…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy
This clinical trial update reports on evaluating an early radiomic signature in patients with metastatic pancreatic adenocarcinoma treated w…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Early Recurrence After Surgery for Pancreatic Cancer
An ongoing ClinicalTrials.gov study is examining early recurrence after pancreatic cancer surgery (pancreatic ductal adenocarcinoma) and is …
-
CLINICAL_TRIALS withdrawal · 2025-11-18Clinical Trial Update: FOLFIRINOX + NIS793 in Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating the combination of FOLFIRINOX and NIS793 in pancreatic cancer has been terminated.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resectable Pancreatic Cancer [NA]
An update on the DISSECT study evaluating peri-adventitial SMA dissection during pancreaticoduodenectomy for resectable pancreatic cancer. T…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating zolbetuximab in combination with chemotherapy for adults with metastatic pancreatic adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma [Phase 1]
Phase 1 trial evaluated CPI-613 (Devimistat) in combination with chemoradiation for pancreatic adenocarcinoma. The study has been terminated…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus anakinra for pancreatic adenocarcinoma is currently recruiting. Sponsored by Baylor Rese…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating a recombinant EphB4-HSA fusion protein in combination with standard chemotherapy for advanced or metastatic solid t…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial investigating Gemcitabine and nab-paclitaxel in combination with the TheraBionic P1 device for metastatic pancreatic adenocarc…
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region [NA]
This document provides an update on a completed clinical trial evaluating respiratory-gated SBRT for pancreatic adenocarcinoma and periampul…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating the safety, tolerability, and efficacy of the modified FOLFIRINOX regimen with or without BNT321 as adjuvant ther…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma [Phase 1]
This document reports a completed Phase 1 exploratory platform trial evaluating immunotherapy combinations with chemotherapy for patients wi…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating immunotherapy with irreversible electroporation for advanced pancreatic adenocarcinoma. Recruitment is ong…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the combination of chemotherapy and irreversible electroporation for advance…